Meningococcal A conjugate 10 dose presentation
Vaccine Trade Name: MenAfriVac
Vaccine Type: Meningococcal A conjugate
Manufacturer: Serum Institute of India Ltd, India
Country of Manufacture: India
Date of prequalification: 23 June 2010
NRA of Record: CDSCO
Pharmaceutical form: lyophilised
Presentation: 10 dose vial (active) + 10 dose ampoule (diluent)
Route of administration: intramuscular
Vaccine Vial Monitor: Type 30
36 months at 2 - 8 °C (active)
60 months at 25°C (diluent)
Secondary Packaging: carton of 50 vials (active) + carton of 50 ampoules (diluent)
Cold Chain volume per dose (cm3): 2.6
Preservative: Thiomersal, 0.01%.
Handling of opened multi-dose vials: WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
The MenAfriVac vaccine can be used in a controlled temperature chain (CTC), for up to four days at ambient temperatures not exceeding 40°C. A CTC is initiated immediately prior to administration, provided that the vaccine has not reached its expiry date and the vaccine vial monitor is still valid. Unopened vaccine vials should be discarded at the end of the four days at 40°C. Reconstituted vaccine should be discarded within six hours. WHO recommends that CTC implementation only occur with appropriate planning, training and guidance. For more information, please contact email@example.com .